Company intelligence / Profile preview

Nirrin Technologies

Billerica, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Nirrin’s Atlas system uses patented near-infrared HPTLS for rapid, quantitative, real-time analysis of complex biologics and advanced therapies, enabling robust process control and reducing manufacturing costs and delays; adopted by major manufacturers such as Boston BioProducts in GMP buffer production and funded by NIH for platform expansion

Modalities: DeviceBiologicMonoclonal antibodyCell therapyGene therapyVaccine manufacturing workflows
Industry: Non-Drug Biotech

Partnerships

Gamma BiosciencesBoston BioProducts

Beyond the preview

Go deeper on Nirrin Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nirrin Technologies.

Explore the full profile